Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody

Ming-Shi Chang

Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody

Ming-Shi Chang (Inventor)

Department of Biochemistry and Molecular Biology

Research output: Patent

Abstract

Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.

Translated title of the contribution	Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody
Original language	English
Patent number	8535674
Publication status	Published - 1800

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{9e8f51f094984c1194d7bbd9ba8737e6,

title = "Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody",

abstract = "Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.",

author = "Ming-Shi Chang",

year = "1800",

language = "English",

type = "Patent",

note = "8535674",

}

TY - PAT

T1 - Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody

AU - Chang, Ming-Shi

PY - 1800

Y1 - 1800

N2 - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.

AB - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.

M3 - Patent

M1 - 8535674

ER -